Fluconazole-Resistant Vulvovaginal Candidosis: An Update on Current Management
Karolina Akinosoglou, Achilleas Livieratos, Konstantinos Asimos, Francesca Donders, Gilbert G G Donders, Georg Hempel · 2024
Read Fluconazole-Resistant Vulvovaginal Candidosis: An Update on Current Management by Karolina Akinosoglou, Achilleas Livieratos, Konstantinos Asimos, Francesca Donders, Gilbert G G Donders, Georg Hempel (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11678211.txt.
Description
Karolina Akinosoglou and five co-authors update how to treat vaginal yeast infections that no longer respond to fluconazole, in a review from 2024. Resistant Candida species, including tougher non-albicans types, are rising worldwide. Standard one-drug habits are part of the problem.
Alternatives reviewed include boric acid, nystatin, and two newer antifungal agents. The authors advise individualized tapering regimens over long fixed high-dose maintenance, keeping doses as low as control allows. They also urge stopping casual antifungal use for symptoms not caused by Candida at all. Careful antibiotic prescribing matters too, since antibiotics disturb the flora and breed resistance.
Catalog record
| CREATOR | Karolina Akinosoglou, Achilleas Livieratos, Konstantinos Asimos, Francesca Donders, Gilbert G G Donders, Georg Hempel |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |